HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR

摘要

The present invention provides a novel heterocyclic compound which is useful as an anti-cancer drug by suppressing protein kinase activity of growth factor receptors such as c-Met, a pharmaceutical composition containing the same, and a method for using the compound. Also, the pharmaceutical composition containing the compound is useful in treating diseases other than cancer, related to signal transduction pathways operated through a receptor of growth factor and anti-vascularization, for example c-Met.